These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21170915)

  • 21. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
    Meng Z; Quan H; Fan L; Kringle R; Sun G
    J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a flexible piecewise linear mixed-effects model in the analysis of randomized cross-over trials.
    Mwangi M; Verbeke G; Njagi EN; Florez AJ; Mwalili S; Ivanova A; Bukania ZN; Molenberghs G
    Pharm Stat; 2024; 23(3):370-384. PubMed ID: 38146135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.
    Yang S; Starks MA; Hernandez AF; Turner EL; Califf RM; O'Connor CM; Mentz RJ; Roy Choudhury K
    Contemp Clin Trials; 2020 Jan; 88():105775. PubMed ID: 31228563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change from baseline and analysis of covariance revisited.
    Senn S
    Stat Med; 2006 Dec; 25(24):4334-44. PubMed ID: 16921578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A summary statistic for measuring change from baseline.
    Donahue RM
    J Biopharm Stat; 1997 May; 7(2):287-99. PubMed ID: 9136070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leveraging prognostic baseline variables to gain precision in randomized trials.
    Colantuoni E; Rosenblum M
    Stat Med; 2015 Aug; 34(18):2602-17. PubMed ID: 25872751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance.
    Durán Pacheco G; Hattendorf J; Colford JM; Mäusezahl D; Smith T
    Stat Med; 2009 Oct; 28(24):2989-3011. PubMed ID: 19672840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stepped wedge designs could reduce the required sample size in cluster randomized trials.
    Woertman W; de Hoop E; Moerbeek M; Zuidema SU; Gerritsen DL; Teerenstra S
    J Clin Epidemiol; 2013 Jul; 66(7):752-8. PubMed ID: 23523551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of cluster randomized trials with repeated cross-sectional binary measurements.
    Ukoumunne OC; Thompson SG
    Stat Med; 2001 Feb; 20(3):417-33. PubMed ID: 11180311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple sample size formula for analysis of covariance in randomized clinical trials.
    Borm GF; Fransen J; Lemmens WA
    J Clin Epidemiol; 2007 Dec; 60(12):1234-8. PubMed ID: 17998077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A note on misspecification in general linear models with correlated errors for the analysis of crossover clinical trials.
    Wang W; Cong N; Chen T; Zhang H; Zhang B
    PLoS One; 2019; 14(3):e0213436. PubMed ID: 30870443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring continuous baseline covariate imbalances in clinical trial data.
    Ciolino JD; Martin RH; Zhao W; Hill MD; Jauch EC; Palesch YY
    Stat Methods Med Res; 2015 Apr; 24(2):255-72. PubMed ID: 21865270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Simulation-Based Comparison of Covariate Adjustment Methods for the Analysis of Randomized Controlled Trials.
    Chaussé P; Liu J; Luta G
    Int J Environ Res Public Health; 2016 Apr; 13(4):414. PubMed ID: 27077870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline adjustments for binary data in repeated cross-sectional cluster randomized trials.
    Nixon RM; Thompson SG
    Stat Med; 2003 Sep; 22(17):2673-92. PubMed ID: 12939779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.